CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Prenetics Global Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Prenetics Global Ltd
Unit 701-706, K11 Atelier King's Road,
728 King's Road, Quarry Bay
Phone: +852 22109588p:+852 22109588 Hong Kong Ticker: PREPRE
Business Summary
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes---

Industries
SIC Code Description
3826 Laboratory analytical instruments
8071 Medical laboratories
2834 Pharmaceutical preparations
6770 Blank checks
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, Co-Founder Sheng WuYeung 45
Co-Founder, Chief Scientific Officer Chi HungTzang 50
Chief Financial Officer Hoi ChunLo 39 1/1/2018 1/1/2018
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ACT Genomics Co., Ltd. 3F., No.345, Xinhu 2nd Rd. Taipei Taiwan, Republic of China
Prenetics EMEA Limited Unit 2 Orpington Business Park Orpington England United Kingdom

Business Names
Business Name
AAC Merger Limited
ACT Biotechnology (Suzhou) Co. Ltd
ACT Biotechnology Shanghai Ltd
42 additional Business Names available in full report.

General Information
Number of Employees: 320 (As of 12/31/2023)
Outstanding Shares: 12,217,226 (As of 6/30/2024)
Stock Exchange: NASD
Federal Tax Id: 981580830


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024